Egon Zehnder
Suche
Select region
Close filter

Chris Patrick

Kontakt

+1 972 728 5951

Kontakt

Chris Patrick is the Global Head of Egon Zehnder’s Technology Officers Practice. Based in Dallas, he advises CEOs and boards on recruitment, assessment, and succession planning for CIOs, CTOs, Chief Cyber Security Officers, and other rapidly evolving enterprise IT, digital, and risk management roles. He works closely with boards on a wide range of technology mandates across multiple industries.

Prior to joining Egon Zehnder, Chris was Chief Information Officer and Vice President of Mergers and Acquisitions at Chatham Technologies, an early-stage telecommunications systems manufacturer. Previously, he was a Senior Manager with Ernst & Young Consulting and an MD80 Project Manager for McDonnell Douglas in Los Angeles.

Chris has a BS from Southern Illinois University and an MBA from the University of Southern California. He is on the board of Children’s Medical Center in Dallas. He’s an avid cyclist who also enjoys skiing and wine.

Kontakt
E-Mail an Chris Patrick
Browse all
Interviews, Artikel und Studien

Thought Leadership by Chris Patrick

CIO - 7 Reasons CIOs Quit (Or Lose Their Jobs)

CIO - 7 Reasons CIOs Quit (Or Lose Their Jobs)

On average, CIOs leave companies every four years, often spurred by broad changes in corporate strategy or role. CIOs also exit because they can’t… Mehr erfahren

Related Experts Around the Globe

Claudio Fernández-Aráoz

Claudio Fernández-Aráoz

Buenos Aires

Claudio Fernández-Aráoz is a senior advisor at Egon Zehnder and was a member of the firm’s global executive committee for more than 10 years. Mehr erfahren

Juliana Rodríguez

Juliana Rodríguez

Bogotá

Juliana Rodríguez Caicedo, based in Bogotá, serves clients across Latin America as an active member of Egon Zehnder’s Financial Services and Consumer… Mehr erfahren

Anna Vichniakova

Anna Vichniakova

London

Anna Vichniakova is based in London and works in Egon Zehnder’s global Health Practice. She serves a range of clients from large pharmaceutical… Mehr erfahren

Back to top